BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhong T, He B, Cao HQ, Tan T, Hu HY, Li YP, Zhang ZW. Treating breast cancer metastasis with cabazitaxel-loaded polymeric micelles. Acta Pharmacol Sin 2017;38:924-30. [PMID: 28504249 DOI: 10.1038/aps.2017.36] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.6] [Reference Citation Analysis]
Number Citing Articles
1 Sun B, Ghosh S, He X, Huang W, Quinn B, Tian M, Jahagirdar D, Mabrouk MT, Ortega J, Zhang Y, Shao S, Lovell JF. Anti-cancer liposomal chemophototherapy using bilayer-localized photosensitizer and cabazitaxel. Nano Res . [DOI: 10.1007/s12274-022-4090-3] [Reference Citation Analysis]
2 Wang Y, Gong X, Li J, Wang H, Xu X, Wu Y, Wang J, Wang S, Li Y, Zhang Z. M2 macrophage microvesicle-inspired nanovehicles improve accessibility to cancer cells and cancer stem cells in tumors. J Nanobiotechnology 2021;19:397. [PMID: 34838042 DOI: 10.1186/s12951-021-01143-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
3 Chand P, Kumar H, Badduri N, Gupta NV, Bettada VG, Madhunapantula SV, Kesharwani SS, Dey S, Jain V. Design and evaluation of cabazitaxel loaded NLCs against breast cancer cell lines. Colloids and Surfaces B: Biointerfaces 2021;199:111535. [DOI: 10.1016/j.colsurfb.2020.111535] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 11.0] [Reference Citation Analysis]
4 Dahiya S, Dahiya R. Organic nanocarriers for targeted delivery of anticancer agents. Advanced Drug Delivery Systems in the Management of Cancer 2021. [DOI: 10.1016/b978-0-323-85503-7.00010-9] [Reference Citation Analysis]
5 Sun B, Jing H, Mabrouk MT, Zhang Y, Jin H, Lovell JF. A surfactant-stripped cabazitaxel micelle formulation optimized with accelerated storage stability. Pharm Dev Technol 2020;25:1281-8. [PMID: 32892678 DOI: 10.1080/10837450.2020.1818780] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
6 Zhao Z, Li Y, Liu H, Jain A, Patel PV, Cheng K. Co-delivery of IKBKE siRNA and cabazitaxel by hybrid nanocomplex inhibits invasiveness and growth of triple-negative breast cancer. Sci Adv 2020;6:eabb0616. [PMID: 32832636 DOI: 10.1126/sciadv.abb0616] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 13.5] [Reference Citation Analysis]
7 Zheng C, Li Y, Peng Z, He X, Tao J, Ge L, Sun Y, Wu Y. A composite nanocarrier to inhibit precipitation of the weakly basic drug in the gastrointestinal tract. Drug Deliv 2020;27:712-22. [PMID: 32397763 DOI: 10.1080/10717544.2020.1760402] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
8 Li Z, Xuan Z, Chen J, Song W, Zhang S, Jin C, Zhou M, Zheng S, Song P. Inhibiting the NF-κB pathway enhances the antitumor effect of cabazitaxel by downregulating Bcl-2 in pancreatic cancer. Int J Oncol 2020;57:161-70. [PMID: 32377719 DOI: 10.3892/ijo.2020.5053] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
9 Li K, Liu W, Zhao Q, Wu C, Fan C, Lai H, Li S. Combination of tanshinone IIA and doxorubicin possesses synergism and attenuation effects on doxorubicin in the treatment of breast cancer. Phytotherapy Research 2019;33:1658-69. [DOI: 10.1002/ptr.6353] [Cited by in Crossref: 26] [Cited by in F6Publishing: 30] [Article Influence: 8.7] [Reference Citation Analysis]
10 Kommineni N, Mahira S, Domb AJ, Khan W. Cabazitaxel-Loaded Nanocarriers for Cancer Therapy with Reduced Side Effects. Pharmaceutics. 2019;11. [PMID: 30934535 DOI: 10.3390/pharmaceutics11030141] [Cited by in Crossref: 22] [Cited by in F6Publishing: 25] [Article Influence: 7.3] [Reference Citation Analysis]
11 Zhang Z, Wang H, Tan T, Li J, Wang Z, Li Y. Rational Design of Nanoparticles with Deep Tumor Penetration for Effective Treatment of Tumor Metastasis. Adv Funct Mater 2018;28:1801840. [DOI: 10.1002/adfm.201801840] [Cited by in Crossref: 75] [Cited by in F6Publishing: 77] [Article Influence: 18.8] [Reference Citation Analysis]
12 He B, Tan T, Wang H, Hu H, Wang Z, Wang J, Li J, Sun K, Zhang Z, Li Y. Rational Design of Tumor Microenvironment-Activated Micelles for Programed Targeting of Breast Cancer Metastasis. Adv Funct Mater 2018;28:1705622. [DOI: 10.1002/adfm.201705622] [Cited by in Crossref: 41] [Cited by in F6Publishing: 41] [Article Influence: 8.2] [Reference Citation Analysis]
13 Huang YZ, Li YP. Cancer nanobiotechnolgy. Acta Pharmacol Sin 2017;38:735-7. [PMID: 28569768 DOI: 10.1038/aps.2017.48] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]